EX-23.1 3 tern-ex23_1.htm EX-23.1 EX-23.1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

 

 

We consent to the incorporation by reference in the Registration Statement (Form S-8) pertaining to the 2022 Employee Inducement Award Plan of our report dated March 7, 2022, with respect to the consolidated financial statements of Terns Pharmaceuticals, Inc. included in its Annual Report (Form 10-K) for the year ended December 31, 2021, filed with the Securities and Exchange Commission.

 

 

 

 

/s/ Ernst & Young LLP

 

 

San Jose, California

November 9, 2022